Sat.Feb 13, 2021 - Fri.Feb 19, 2021

Pfizer set to double weekly production of coronavirus vaccine

Bio Pharma Dive

The drugmaker will use production lines at its plant in McPherson, Kansas to help fill vaccine vials, company CEO Albert Bourla said Friday

Pharma running online ads on vaccine misinformation sites

World of DTC Marketing

SUMMARY: More than 42,000 programmatic ads from 4,315 brands are running on websites spouting misinformation about the vaccine and COVID over the past year. Included in the programmatic ad errors is Pfizer, who developed a leading COVID vaccine. When will pharma stop using programmatic online ads?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

University of Oregon Campus Could Be Cornerstone of New Biotech Hotspot

BioSpace

A new biotech hotspot could be on the horizon in Oregon thanks to a $500 million gift to the University of Oregon from Nike co-founder Phil Knight, an alumnus of the university

105
105

Membrane building blocks play decisive role in controlling cell growth

Scienmag

Credit: Marta Fratini Lipids are the building blocks of a cell’s envelope – the cell membrane. In addition to their structural function, some lipids also play a regulatory role and decisively influence cell growth.

10 biotechs become 1: Centessa launches with $250M to prove unorthodox R&D model

Bio Pharma Dive

The new company will be led by Saurabh Saha, a former Bristol Myers executive, and Moncef Slaoui, who until recently led the U.S. government's coronavirus vaccine program

How much to spend on DTC TV

World of DTC Marketing

SUMMARY: By far, the biggest question I get as a consultant is, “how much should we spend on DTC ads?” ” It’s important to understand that no formula can be applied across all health conditions and products.

Turning Point Therapeutics is ‘Cycling’ Toward a Precise Cure for Cancer

BioSpace

The company's lead drug candidate, Reprotrectinib, is currently in Phase I/II clinical studies to target non-small cell lung cancer (NSCLC) in patients with a ROS1 or NTRK metastatic mutation

Drugs 100

More Trending

Gates Foundation backs Novartis' search for a sickle cell cure

Bio Pharma Dive

An initial grant will support a research team at Novartis' R&D labs whose sole focus will be to develop a single-administration gene therapy for sickle cell disease

DTC Review: Nucala

World of DTC Marketing

THE SHORT: According to Medical News Today “in the United States (U.S.), an estimated 25.7 million people have some form of asthma , and 15 percent of these people have severe asthma that is difficult to control with standard medications.

Impact of COVID-19 on Clinical Research in Malaysia

Journal for Clinical Studies

The novel coronavirus disease (COVID-19) pandemic has impacted global economies. These disruptions, also experienced by the global industry-sponsored research (ISR)… Current features Volume 13 Issue 1

Parents Say COVID-19 has disrupted children’s dental care

Scienmag

1 in 3 parents feel COVID-19 has made it harder to get preventive dental care for their child; families with Medicaid may face greater barriers. Credit: C.S. Mott Children’s Hospital National Poll on Children’s Health at Michigan Medicine. ANN ARBOR, Mich.

Bluebird stops studies of sickle cell gene therapy after new cancer cases

Bio Pharma Dive

The biotech is also suspending sales of its related treatment Zynteglo following a leukemia diagnosis in a clinical trial volunteer and a case of a cancer-like bone marrow disease in another

Pharma needs to give the boot to McKinsey

World of DTC Marketing

SUMMARY: This month, McKinsey agreed to pay nearly $600m to settle claims that its advice had exacerbated the deadly US opioid crisis, yet pharma views McKinsey as business gurus. This has to stop, and NOW!

Sales 140

South Africa starts administering Janssen COVID-19 vaccine to health workers

BioPharma Reporter

South Africa has started administering the Janssen COVID-19 vaccine to health workers this week after the first doses arrived in the country. Meanwhile, J&J has submitted an application for Conditional Marketing Authorisation in the EU, following its application for EUA in the US.

AI tool aims to help doctors, patients better prepare for surgery

Scienmag

Credit: Purdue University/Mohammad Rahman WEST LAFAYETTE, Ind. – A new tool using an artificial intelligence platform may help doctors better prepare patients for surgery.

Pfizer, BioNTech ask FDA approval to ease temperature requirements for coronavirus shot

Bio Pharma Dive

Testing showed the vaccine could be safely stored at normal freezer temperatures, rather than the roughly minus 70 degrees Celsius now specified. The change, if cleared by the agency, will help distribution

Project Farma: Manufacturing Skills Gap Creates Bottleneck for Cell and Gene Therapy

BioSpace

The skills gap in cell and gene therapy is creating a bottleneck that is slowing the abilities of innovative therapies to reach patients, delaying manufacturing scaleup and increasing learning and development costs

AstraZeneca/Oxford to trial COVID-19 vaccine in children

BioPharma Reporter

A new trial for the AstraZeneca/Oxford COVID-19 vaccine will investigate the efficacy of the vaccine in children aged six and over. Bio Developments

Higher elevation birds sport thicker down “jackets” to survive the cold

Scienmag

Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems

Bio Pharma Dive

For $125 million up front, Lilly secures rights to a drug about to enter mid-stage testing for autoimmune and inflammatory diseases, as well as preclinical assets targeting the central nervous system

Drugs 195

Novavax Preps to Distribute 1.1 Billion COVID-19 Vaccine Doses Worldwide

BioSpace

The vaccine will be manufactured and distributed around the world by Novavax and Serum Institute of India (SII

What CROs or sponsors can do for sites to be more efficient

Cloudbyz

The success of a clinical trial depends on the successful collaboration between sites, CROs, and sponsors. This means that timely and effective communication between the sites and the sponsors are pivotal.

Commuters are inhaling unacceptably high levels of carcinogens

Scienmag

Twenty minutes or longer in the car also raises risk of birth defects Credit: Stan Lim/UCR A new study finds that California’s commuters are likely inhaling chemicals at levels that increase the risk for cancer and birth defects. As with most chemicals, the poison is in the amount.

67

GSK returns to Vir with expanded deal to develop drugs for flu, other viruses

Bio Pharma Dive

The British drugmaker will pay the San Francisco-based biotech $225 million upfront, while also investing another $120 million in Vir shares

Amgen Moves One Step Closer to First Approved KRAS Inhibitor for Lung Cancer

BioSpace

The U.S. FDA granted Amgen Priority Review for sotorasib for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), after at least one previous systemic therapy

91

Syntegon touts new tech at 2021 Virtual Pharma Expo

Syntegon Technology Pharma Blog

Liquid Dosage aseptic Fill-Finish Flexible Filling Portfolio Klaus Ullherr Syntegon

63

Aspirin preferred to prevent blood clots in kids after heart surgery

Scienmag

Credit: jesse orrico Aspirin should be favoured over warfarin to prevent blood clotting in children who undergo a surgery that replumbs their hearts, according to a new study.

eReconciliation tool: A new software to facilitate Safety Data Reconciliation between clinical and safety databases

Bio Pharma Dive

Simplify serious adverse events reconciliation operations with a customizable and GxP validated platform solution

172
172

You Got the COVID-19 Vaccine - Now What?

BioSpace

With the COVID-19 vaccine rollout underway and a renewed sense of hope stemming from an aggressive vaccine dispersal plan, a common question has begun to emerge

Could CRISPR cure HIV? US biotech Excision raises $60m to find out

Pharma Phorum

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues.

New technology enables predictive design of engineered human cells

Scienmag

Capability could accelerate the development of new treatments for diseases Credit: Justin Muir Northwestern University synthetic biologist Joshua Leonard used to build devices when he was a child using electronic kits.

Novartis expects sales lift from expanded heart drug approval

Bio Pharma Dive

The Swiss drugmaker's pill Entresto is now cleared in the U.S. for use in patients with stronger hearts, expanding the eligible population by two-thirds

Sales 171

NKarta Therapeutics’ NKT Cells Elicit Better Response than CAR-T Cells Alone

BioSpace

NKarta Therapeutics is using engineered chimeric antigen receptor natural killer T cells (CAR-NKT cells) for allogeneic therapy, showing substantial benefits both in vitro and in vivo, according to James Trager, CSO, speaking Wednesday at the virtual CAR-TCR Summit – Europe

4 principles for the future of pharma marketing

Pharma Phorum

COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. .

Study suggests link between DNA and marriage satisfaction in newlyweds

Scienmag

Variation in a specific gene could be related to traits that are beneficial to bonding and relationship satisfaction in the first years of a marriage Credit: Russell Cothren FAYETTEVILLE, Ark.

DNA 65

Investment firm raises $300M to fund medical research for overlooked diseases

Bio Pharma Dive

Adjuvant Capital's first fund drew interest from Merck and Novartis as well as philanthropies and other investment firms

Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition

BioSpace

Charles River Laboratories will acquire Cognate BioServices in an $875 million cash deal that will significantly expand the company’s capabilities in the high-growth cell and gene therapy sector